MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, RPTX made $11,620K in revenue. $3,280K in net income. Net profit margin of 28.23%.

Income Overview

Revenue
$11,620K
Net Income
$3,280K
Net Profit Margin
28.23%
EPS
$0.08
Unit: Thousand (K) dollars

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration agreements
11,620 250 -13,369*
Research and development, net of tax credits
7,502 14,283 20,270 -9,370*
General and administrative
4,548 6,029 7,652 10,348*
Restructuring
1,826 3,384 3,265 -3,202*
Total operating expenses
13,876 23,696 31,187 -2,224*
Gain on sale of technology and other assets
130 5,666 --
Gain on termination of collaboration agreement
3,257 ---
Income (gain) from operations
1,131 -17,780 -31,187 15,593*
Other expense, net
-18 22 -11*
Realized and unrealized (gain) loss on foreign exchange
-41 66 -2 55*
Interest income
2,224 1,236 1,538 2,855*
Other income (expense), net
89 ---
Total other income, net
2,272 1,284 1,514 2,921*
Income (gain) before income taxes
3,403 -16,496 -29,673 18,514*
Income tax expense
145 248 370 -15*
Net income (gain)
3,258 -16,744 -30,043 18,529*
Unrealized loss on available-for-sale marketable securities
-0 --
Unrealized loss (gain) on available-for-sale marketable securities
22 -17 -45 -796
Total other comprehensive income (gain)
22 -17 -45 -796*
Comprehensive income (gain)
3,280 -16,761 -30,088 17,733
Basic EPS
0.08 -0.39 -0.71 0.419
Diluted EPS
0.08 -0.39 -0.71 0.419
Basic Average Shares
42,965,529 42,921,936 42,591,730 42,369,553
Diluted Average Shares
43,051,934 42,921,936 42,591,730 42,369,553
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$2,224K (-11.46%↓ Y/Y)Other income(expense), net$89K Collaboration agreements$11,620K Gain on terminationof collaboration...$3,257K Gain on sale oftechnology and other assets$130K Total other income,net$2,272K (-7.30%↓ Y/Y)Income (gain) fromoperations$1,131K (103.11%↑ Y/Y)Realized and unrealized(gain) loss on foreign...-$41K (-115.79%↓ Y/Y)Total operatingexpenses$13,876K (-61.85%↓ Y/Y)Income (gain) beforeincome taxes$3,403K (110.03%↑ Y/Y)Unrealized loss (gain) onavailable-for-sale marketable...$22K (-91.97%↓ Y/Y)Research anddevelopment, net of tax...$7,502K (-73.59%↓ Y/Y)General andadministrative$4,548K (-29.42%↓ Y/Y)Restructuring$1,826K (19.58%↑ Y/Y)Net income (gain)$3,258K (109.47%↑ Y/Y)Total othercomprehensive income (gain)$22K (-91.97%↓ Y/Y)Income tax expense$145K (-70.10%↓ Y/Y)Comprehensive income (gain)$3,280K (109.61%↑ Y/Y)

Repare Therapeutics Inc. (RPTX)

Repare Therapeutics Inc. (RPTX)